Yo Han Kim

428 total citations
33 papers, 331 citations indexed

About

Yo Han Kim is a scholar working on Surgery, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yo Han Kim has authored 33 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Pharmacology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yo Han Kim's work include Diabetes Treatment and Management (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). Yo Han Kim is often cited by papers focused on Diabetes Treatment and Management (5 papers), Blood Pressure and Hypertension Studies (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). Yo Han Kim collaborates with scholars based in South Korea and United States. Yo Han Kim's co-authors include Kyun‐Seop Bae, Hee Youn Choi, Hyeong‐Seok Lim, Geun Seog Song, Sungpil Han, Song Am Lee, Woo Surng Lee, Seong Jun Park, Jae Joon Hwang and Sun Young Cho and has published in prestigious journals such as Cancer Research, Alimentary Pharmacology & Therapeutics and Clinical Therapeutics.

In The Last Decade

Yo Han Kim

32 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yo Han Kim South Korea 10 145 97 67 58 54 33 331
Ishizaki Japan 4 235 1.6× 215 2.2× 78 1.2× 28 0.5× 53 1.0× 7 421
Seong Bok Jang South Korea 13 122 0.8× 27 0.3× 37 0.6× 47 0.8× 100 1.9× 34 387
Choon Ok Kim South Korea 12 90 0.6× 19 0.2× 30 0.4× 73 1.3× 130 2.4× 48 376
K. Frislid Norway 14 216 1.5× 126 1.3× 73 1.1× 96 1.7× 68 1.3× 22 516
H. W. Radtke Germany 11 75 0.5× 44 0.5× 50 0.7× 143 2.5× 51 0.9× 17 579
P O Lagerström Sweden 9 132 0.9× 84 0.9× 47 0.7× 55 0.9× 67 1.2× 14 428
Yulia Hirschberg United States 13 104 0.7× 16 0.2× 51 0.8× 113 1.9× 33 0.6× 23 380
Robin O'Connor‐Semmes United States 13 153 1.1× 31 0.3× 29 0.4× 157 2.7× 60 1.1× 18 527
Gordon Mallarkey United Kingdom 10 81 0.6× 62 0.6× 24 0.4× 52 0.9× 21 0.4× 22 334
MJ Langman United Kingdom 8 76 0.5× 44 0.5× 29 0.4× 50 0.9× 108 2.0× 11 424

Countries citing papers authored by Yo Han Kim

Since Specialization
Citations

This map shows the geographic impact of Yo Han Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yo Han Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yo Han Kim more than expected).

Fields of papers citing papers by Yo Han Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yo Han Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yo Han Kim. The network helps show where Yo Han Kim may publish in the future.

Co-authorship network of co-authors of Yo Han Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Yo Han Kim. A scholar is included among the top collaborators of Yo Han Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yo Han Kim. Yo Han Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Yo Han, et al.. (2025). Experimental investigation of the effect of operating conditions on internal flow behavior in APR1000. Nuclear Engineering and Technology. 57(9). 103669–103669.
2.
Han, Sungpil, Hee Youn Choi, Yo Han Kim, et al.. (2021). Effect of Food on the Pharmacokinetics and Pharmacodynamics of a Single Oral Dose of Tegoprazan. Clinical Therapeutics. 43(8). 1371–1380. 20 indexed citations
3.
Park, Jae Bum, Song Am Lee, Woo Surng Lee, Yo Han Kim, & Jae Joon Hwang. (2018). The management of chemical pleurodesis with viscum album in patients with persistent air leakage. Journal of Thoracic Disease. 10(1). 371–376. 7 indexed citations
4.
Bae, Kyun‐Seop, et al.. (2015). Pharmacokinetic interaction between udenafil and dapoxetine: a randomized, open-labeled crossover study in healthy male volunteers. Drug Design Development and Therapy. 9. 1209–1209. 7 indexed citations
5.
Kim, Yo Han, Sang‐Heon Cho, Jong‐Lyul Ghim, et al.. (2015). Pharmacokinetic comparison of sustained- and immediate-release formulations of cilostazol after multiple oral doses in fed healthy male Korean volunteers. Drug Design Development and Therapy. 9. 3571–3571. 8 indexed citations
6.
Kim, Yo Han, Hee Youn Choi, Hyeong‐Seok Lim, et al.. (2015). Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers. Drug Design Development and Therapy. 9. 1419–1419. 16 indexed citations
7.
Choi, Hee Youn, Yo Han Kim, Donghyun Hong, et al.. (2015). Therapeutic dosage assessment based on population pharmacokinetics of a novel single-dose transdermal donepezil patch in healthy volunteers. European Journal of Clinical Pharmacology. 71(8). 967–977. 7 indexed citations
8.
Bae, Kyun‐Seop, et al.. (2015). Single and multiple dose pharmacokinetics and tolerability of HX-1171, a novel antioxidant, in healthy volunteers. Drug Design Development and Therapy. 9. 1735–1735. 3 indexed citations
11.
Kim, Yo Han, et al.. (2014). Tolerability and Pharmacokinetics of Two Formulations of Megestrol Acetate under Fed Conditions in Healthy Volunteers. Clinical Therapeutics. 37(2). 439–447. 2 indexed citations
13.
Choi, Hee Youn, et al.. (2014). Evaluation of the pharmacokinetics of the DPP-4 inhibitor gemigliptin when coadministered with rosuvastatin or irbesartan to healthy subjects. Current Medical Research and Opinion. 31(2). 229–241. 9 indexed citations
14.
Kim, Jong Duk, Hyun Keun Chee, Je Kyoun Shin, et al.. (2014). Novel Early Predictor of Acute Kidney Injury after Open Heart Surgery under Cadiopulmonary Bypass Using Plasma Neutrophil Gelatinase-Associated Lipocalin. The Korean Journal of Thoracic and Cardiovascular Surgery. 47(3). 240–248. 5 indexed citations
15.
Lim, Hyeong‐Seok, et al.. (2013). Pharmacokinetic Interactions Between Eperisone Hydrochloride and Aceclofenac: A Randomized, Open-Label, Crossover Study of Healthy Korean Men. Clinical Therapeutics. 35(10). 1528–1535. 11 indexed citations
16.
Choi, Hee Youn, et al.. (2013). Pharmacokinetics, Tolerability, and Safety of the Single Oral Administration of AGSAV301 vs Exforge: A Randomized Crossover Study of Healthy Male Volunteers. American Journal of Cardiovascular Drugs. 14(1). 63–72. 2 indexed citations
17.
Kim, Yo Han, et al.. (2012). Pharmacokinetic Interaction of Telmisartan With S-Amlodipine: An Open-Label, Two-Period Crossover Study in Healthy Korean Male Volunteers. Clinical Therapeutics. 34(7). 1625–1635. 16 indexed citations
18.
Lim, Hyeong-Seok, Sang‐Heon Cho, Jong‐Lyul Ghim, et al.. (2012). Assessment of the influence of severe renal impairment on the pharmacokinetics of mirodenafil in Korean male volunteers. International Journal of Clinical Pharmacology and Therapeutics. 50(12). 880–888. 2 indexed citations
20.
Kim, Yo Han, et al.. (2012). A single-dose, crossover study comparing the pharmacokinetics and pharmacodynamics of 2 formulations of metformin in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. 50(8). 605–613. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026